Medical devices, healthcare technology and the business of care
510(k) clearance · K253602

Precision S 4K Sinuscope

Stryker Endoscopy · Decision date Jun 4, 2026

FDA DECISIONK253602

What did the FDA decide?

FDA records K253602 as a 510(k) premarket notification, with a decision dated Jun 4, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Neurology
Decision date
Jun 4, 2026

FDA source record

Regulatory record facts

Identifier
K253602
Regulatory pathway
510(k) premarket notification
Product code
GWG
Decision code
SESE
Decision date
Jun 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Endoscope, Neurological.

Product code
GWG
FDA device class
2

FDA decision timeline

  1. K253602 received

    Application receipt date recorded by FDA.

  2. K253602 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GWG

Product / regulatory recordCompanyPathwayDecision dateSource
VPIX MEDICAL, INC.510(k) clearanceOct 16, 2026FDA
Karl Storz SE & CO. KG510(k) clearanceOct 14, 2026FDA
Stryker Instruments510(k) clearanceMay 8, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Stryker Endoscopy

Headquarters
Not reported
Brand website
stryker.com
FDA applicant address
San Jose, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records